February 2018

Riffyn Awarded Its First US Patent for Experiment Design and Data Analytics

Tue, 27/02/2018 - 07:30
Newly patented hypergraph data model solidifies Riffyn’s position in the expanding market for linked-data analytics and AI in biotech and pharmaceutical R&D

Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccines

Mon, 26/02/2018 - 07:30
Prokarium today announced the completion of a $10 million investment round. The round was led by Riyadh Valley Company, followed by Prokarium’s original investor Flerie Invest as well as Korea Investment Partners.
Bioforward poster

OBN Launch BioForward® Conference

Mon, 19/02/2018 - 12:00
The ‘Roadmap for Growth’ Life Sciences Event

Naviswiss Hip Navigation receives CE Approval and CHF 3.5 million Private Equity

Thu, 08/02/2018 - 17:15
Brugg AG, Switzerland, 8th February 2018 / Sciad Newswire / Naviswiss, an independent medical technology company specialized in

Positive results achieved in ReViral's Phase IIa RSV challenge study

Mon, 05/02/2018 - 07:30
ReViral’s RV521 fusion inhibitor produces highly significant reduction in viral load and clinical symptoms

Domainex appoints Dr Kevin Doyle as Head of Chemistry

Thu, 01/02/2018 - 07:30
Cambridge, UK, 1st February 2018 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is p